Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
Open Access
- 8 October 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 6 (4), 78
- https://doi.org/10.3390/ijns6040078
Abstract
Newborn screening (NBS) for mucopolysaccharidosis type I (MPS I, Hurler syndrome) is currently conducted in about two-fifths of the NBS programs in the United States and in a few other countries. Screening is performed by measurement of residual activity of the enzyme alpha-l-iduronidase in dried blood spots using either tandem mass spectrometry or digital microfluidic fluorometry (DMF). In this article, we focus on the development and practical experience of using DMF to screen for MPS I in the USA. By means of their responses to a questionnaire, we determined for each responding program that is screening for MPS I using DMF the screen positive rate, follow-up methods, and classification of confirmed cases as either severe or attenuated. Overall, the results show that at the time of reporting, over 1.3 million newborns in the US were screened for MPS I using DMF, 2094 (0.173%) of whom were screen positive. Of these, severe MPS I was confirmed in five cases, attenuated MPS I was confirmed in two cases, and undetermined phenotype was reported in one case. We conclude that DMF is an effective and economical method to screen for MPS I and recommend second-tier testing owing to high screen positive rates. Preliminary results of NBS for MPS II and MPS III using DMF are discussed.Keywords
This publication has 37 references indexed in Scilit:
- Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platformClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spotsMolecular Genetics and Metabolism, 2012
- Digital Microfluidic Platform for Multiplexing Enzyme Assays: Implications for Lysosomal Storage Disease Screening in NewbornsClinical Chemistry, 2011
- Newborn screening for lysosomal storage disordersSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2011
- Newborn Screening of Lysosomal Storage DisordersClinical Chemistry, 2010
- Digital Microfluidics: A Future Technology in the Newborn Screening Laboratory?Seminars in Perinatology, 2010
- Tandem Mass Spectrometric Analysis of Dried Blood Spots for Screening of Mucopolysaccharidosis I in NewbornsClinical Chemistry, 2005
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004
- Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paperClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Krabbe DiseaseClinical Chemistry, 2004